Nkarta, Inc. Number of Operating Segments
Nkarta, Inc. (NKTX) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-10
- Nkarta, Inc. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Nkarta, Inc. number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Nkarta, Inc. number of operating segments for the quarter ending 2024-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Nkarta, Inc. number of operating segments for the quarter ending 2023-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Nkarta, Inc. number of operating segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Nkarta, Inc. number of operating segments for fiscal 2024 was 1.00 Segment, a 0.00% change from fiscal 2023.
- Nkarta, Inc. number of operating segments for fiscal 2023 was 1.00 Segment, a 0.00% change from fiscal 2022.
- Nkarta, Inc. number of operating segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-26 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 1.00 Segment 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | 1.00 Segment 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-03-21 | |||
| 2023-09-30 | 1.00 Segment 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 1.00 Segment 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | 1.00 Segment 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 1.00 Segment 10-K · filed 2023-03-16 | |||
| 2022-09-30 | 1.00 Segment 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 1.00 Segment 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 1.00 Segment 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 1.00 Segment 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.00 Segment 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 1.00 Segment 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-03-25 | |||
| 2020-09-30 | 1.00 Segment 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |